Fierce Biotech White Logo Fierce Biotech White Logo
Webinar

Rare Genetics, Real Solutions: Connecting Patients with Clinical Trials

ET
60 Minutes

With 80% of rare diseases having a genetic basis, the role of genetic counselors is critical to finding patients whose molecular diagnoses match study criteria for new targeted gene therapies. How can life sciences organizations effectively identify and recruit participants with specific genetic variants? How can they engage providers and raise awareness of gene therapies for the patients who need them most?

We will explore how incorporating comprehensive genetic services, like genetic testing access programs and clinical trial matching services, can increase identification of patients who meet program-specific inclusion/exclusion criteria, helping more patients benefit from life-changing therapeutics.

Learn how genetic services can:

  • Improve access to genetic testing
  • Identify eligible patients more effectively
  • Boost patient and provider awareness of clinical trials and therapies

Join us as we provide real-world examples of how genetic services have accelerated rare disease clinical trials and therapy access, offering valuable insights for life sciences leaders.

Speakers

AmyShea

Amy Shea

Director, Diagnostics & Strategic Initiatives
Ionis Pharmaceuticals

Amy has over 20 years of experience in diagnostics & genetics. Her passion for genetics started at UC Davis where she earned her Bachelor of Science in Genetics and expanded in her knowledge at diagnostic laboratories including Sequenom (now LabCorp), PerkinElmer (now Revvity), Emory Genetics & Gene Therapy at Weill Cornell Medical College. From there she transitioned into the genetic rare disease space where she focuses more on patients. In her current role at Ionis Pharmaceuticals/Akcea Therapeutics she has oversight of sponsored genetic testing and genetic counseling programs. Her team applies the science of clinical genetics to support strategic drug development and the adoption of IONIS precision medicines. 

Collen Caleshu

Colleen Caleshu, MS, CGC

Senior Director, Research & RWD
Genome Medical

Colleen is clinician-scientist genetic counselor and an internationally recognized leader in cardiovascular genetics. Colleen prioritizes research questions that help move the care of patients with genetic conditions forward. Her research has covered use of digital tools in genomic medicine, mindfulness meditation for genetic counselors, psychotherapeutic aspects of genetic counseling, interpretation of genetic and genomic tests in cardiology, and integration of genetic counselors into cardiology. Colleen has advised multiple genetics and pharmaceutical companies on their strategy in the cardiovascular, genetic counseling, and genetic testing spaces.

sarahhs423.jpg

Sara Riordan, MS, CGC

Vice President, Strategy
Genome Medical

Sara leads Genome Medical’s strategy to apply real world data and genetics expertise to accelerate patient accrual for clinical trials and post-commercial therapies. Prior to joining Genome Medical, she led clinical and research programs at biotech and precision diagnostics organizations such as Thermo Fisher Scientific, Life Technologies, Oncocyte and Unified Patient Network. Sara has also led many early-stage companies in developing and commercializing genomic services and applications. In addition, in 2021, she served as the President of the National Society of Genetic Counselors.

Register here!

Already registered? Click here to login.
Date/Time:
ET
Duration:
60 Minutes